Search research articles
Contact Us
Filters
Showing results (411-420 of 560) with videos related to
Page
of 56
Sort By:
American Journal of Obstetrics and Gynecology
|
May 18, 2010
Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
Richard G Moore, Moune Jabre-Raughley, Amy K Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Project Zero Delay: a process for accelerating the activation of cancer clinical trials
Razelle Kurzrock, Susan Pilat, Marcel Bartolazzi, et al.
Molecular Oncology
|
March 12, 2022
SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK
Xiu Shi, Xuejiao Yu, Juan Wang, et al.
Cancer
|
April 15, 2011
Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy
Min-Yu Chen, Warren S-L Liao, Zhen Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2004
Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer
Gordon J S Rustin, Robert C Bast, Gary J Kelloff, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 15, 2025
GlycoKnow Ovarian: a Glycoprotein-based, Serum Diagnostic to Distinguish Ovarian Cancers from Benign Pelvic Masses
Daniel Serie, Kaitlynn Moser, Maurice Wong, et al.
AIDS (London, England)
|
February 15, 2021
Risk of adverse coronavirus disease 2019 outcomes for people living with HIV
Maya M Mellor, Anne C Bast, Nicholas R Jones, et al.
Gynecologic Oncology
|
December 7, 2007
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
Richard G Moore, Amy K Brown, M Craig Miller, et al.
Journal of Medicinal Chemistry
|
April 14, 2011
Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3
Pijus K Mandal, Fengqin Gao, Zhen Lu, et al.
Cancer
|
August 27, 1999
Communication skills training in oncology. Description and preliminary outcomes of workshops on breaking bad news and managing patient reactions to illness
W F Baile, A P Kudelka, E A Beale, et al.
Page
of 56
Search research articles
Search
Showing results (411-420 of 560) with videos related to
Sort By:
Page
of 56
American Journal of Obstetrics and Gynecology
|
May 18, 2010
Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
Richard G Moore, Moune Jabre-Raughley, Amy K Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Project Zero Delay: a process for accelerating the activation of cancer clinical trials
Razelle Kurzrock, Susan Pilat, Marcel Bartolazzi, et al.
Molecular Oncology
|
March 12, 2022
SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK
Xiu Shi, Xuejiao Yu, Juan Wang, et al.
Cancer
|
April 15, 2011
Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy
Min-Yu Chen, Warren S-L Liao, Zhen Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2004
Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer
Gordon J S Rustin, Robert C Bast, Gary J Kelloff, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 15, 2025
GlycoKnow Ovarian: a Glycoprotein-based, Serum Diagnostic to Distinguish Ovarian Cancers from Benign Pelvic Masses
Daniel Serie, Kaitlynn Moser, Maurice Wong, et al.
AIDS (London, England)
|
February 15, 2021
Risk of adverse coronavirus disease 2019 outcomes for people living with HIV
Maya M Mellor, Anne C Bast, Nicholas R Jones, et al.
Gynecologic Oncology
|
December 7, 2007
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
Richard G Moore, Amy K Brown, M Craig Miller, et al.
Journal of Medicinal Chemistry
|
April 14, 2011
Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3
Pijus K Mandal, Fengqin Gao, Zhen Lu, et al.
Cancer
|
August 27, 1999
Communication skills training in oncology. Description and preliminary outcomes of workshops on breaking bad news and managing patient reactions to illness
W F Baile, A P Kudelka, E A Beale, et al.
Page
of 56